Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH): Guosheng Haitong private enterprise high-quality development fund's stake has decreased to below 5%.

Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) issued an announcement on September 24, 2024, stating that its shareholder, Shanghai Guosheng Capital Management Co., Ltd. - Shanghai Guosheng Haitong Private Equity Fund Partnership Enterprise (Limited Partnership) (referred to as "Guosheng Haitong Private Enterprise High-quality Development Fund"), has reduced its holdings of the company's unrestricted tradable shares by 9900 shares through centralized bidding on the Shanghai Stock Exchange, representing 0.002416% of the company's total share capital. After this equity change, Guosheng Haitong Private Enterprise High-quality Development Fund's ownership of the company's shares now accounts for 4.999997% of the total share capital, no longer making them a shareholder with over 5% ownership of the company.